Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,694 | -10,437 | -20,131 | -23,657 | -17,315 |
| Depreciation Amortization | 616 | 307 | 1,064 | 769 | 518 |
| Accounts receivable | 1,581 | 1,576 | -1,536 | -204 | 1,491 |
| Accounts payable and accrued liabilities | -894 | -590 | 2,029 | N/A | N/A |
| Other Working Capital | 2,960 | 2,618 | -4,394 | 854 | -1,013 |
| Other Operating Activity | -1,614 | 3,201 | -1,927 | 6,209 | 2,294 |
| Operating Cash Flow | $-8,045 | $-3,325 | $-24,895 | $-16,029 | $-14,025 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57 | 57 | 624 | 560 | 178 |
| PPE Investments | -9 | -57 | -5 | -14 | -14 |
| Purchase Sale Intangibles | -50 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -50 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-2 | $N/A | $619 | $546 | $164 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 25,248 | 13,546 | 5,700 |
| Common Stock Issued | N/A | N/A | 4,507 | N/A | N/A |
| Other Financing Activity | 11,083 | 5,799 | -21,344 | -11,849 | -4,594 |
| Financing Cash Flow | $11,083 | $5,799 | $8,411 | $1,697 | $1,106 |
| Beginning Cash Position | 1,543 | 1,543 | 17,408 | 17,408 | 17,408 |
| End Cash Position | 4,579 | 4,017 | 1,543 | 3,622 | 4,653 |
| Net Cash Flow | $3,036 | $2,474 | $-15,865 | $-13,786 | $-12,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,045 | -3,325 | -24,895 | -16,029 | -14,025 |
| Capital Expenditure | -9 | -57 | -5 | -14 | -14 |
| Free Cash Flow | -8,054 | -3,382 | -24,900 | -16,043 | -14,039 |